Literature DB >> 16508576

High prevalence of newly detected hypertension in hospitalized patients: the value of inhospital 24-h blood pressure measurement.

David Conen1, Benedict Martina, Andre P Perruchoud, Bernd M Leimenstoll.   

Abstract

OBJECTIVE: Screening for hypertension in hospitalized patients could reduce the number of individuals with unrecognized hypertension. We hypothesized that 24-h blood pressure monitoring is an adequate tool to detect unrecognized hypertension among inpatients.
METHODS: Clinically stable inpatients in the Department of Internal Medicine, Department of Visceral Surgery and Department of Orthopaedics were included in the cross-sectional study. Every patient underwent inhospital 24-h blood pressure measurement. Previously unknown hypertension was defined as 24-h blood pressure of at least 125/80 mmHg in the absence of known hypertension. Forty-two patients had an additional 24-h blood pressure measurement after discharge, to compare mean inhospital and outpatient 24-h blood pressure values.
RESULTS: In 314 consecutive inpatients, 24-h blood pressure measurement was performed. Among 139 patients without known hypertension, 53 were hypertensive. The mean routine and 24-h blood pressures in these patients were 135/77 and 137/82 mmHg, respectively. Thirty-seven of these patients had normal routine blood pressure and could be detected only by 24-h blood pressure measurement. Patients with unknown hypertension had a marked cardiovascular risk profile, 26 being at high or very high cardiovascular risk. However, documented cardiovascular disease was present in only seven patients, suggesting that effective treatment could prevent a considerable number of cardiovascular events. The agreement between inhospital and outpatient 24-h blood pressure measurement in 42 patients was good.
CONCLUSIONS: By performing inhospital 24-h blood pressure measurement, a considerable number of patients with previously unknown hypertension can be detected.

Entities:  

Mesh:

Year:  2006        PMID: 16508576     DOI: 10.1097/01.hjh.0000200510.95076.2d

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  6 in total

1.  Antihypertensive medication prescribing patterns in a university teaching hospital.

Authors:  R Neal Axon; Paul J Nietert; Brent M Egan
Journal:  J Clin Hypertens (Greenwich)       Date:  2010-04       Impact factor: 3.738

2.  Retrospective review of the use of as-needed hydralazine and labetalol for the treatment of acute hypertension in hospitalized medicine patients.

Authors:  Michelle F Gaynor; Garth C Wright; Sheryl Vondracek
Journal:  Ther Adv Cardiovasc Dis       Date:  2018-01

3.  Attitudes and practices of resident physicians regarding hypertension in the inpatient setting.

Authors:  Robert Neal Axon; Robin Garrell; Kyle Pfahl; Julie E Fisher; Yumin Zhao; Brent Egan; Alan Weder
Journal:  J Clin Hypertens (Greenwich)       Date:  2010-09       Impact factor: 3.738

4.  Twenty-four-hour ambulatory blood pressure monitoring in very elderly patients: Comparison of in-hospital versus home follow-up results.

Authors:  Claudia Cappelleri; Alin Janoschka; Reto Berli; Sibylle Kohler; Ruediger C Braun-Dullaeus; Ludwig T Heuss; Mathias Wolfrum
Journal:  Medicine (Baltimore)       Date:  2017-08       Impact factor: 1.889

5.  Screening for Hypertension in the INpatient Environment(SHINE): a protocol for a prospective study of diagnostic accuracy among adult hospital patients.

Authors:  Laura C Armitage; Adam Mahdi; Beth K Lawson; Cristian Roman; Thomas Fanshawe; Lionel Tarassenko; Andrew J Farmer; Peter J Watkinson
Journal:  BMJ Open       Date:  2019-12-04       Impact factor: 2.692

6.  Screening for hypertension using emergency department blood pressure measurements can identify patients with undiagnosed hypertension: A systematic review with meta-analysis.

Authors:  Laura C Armitage; Maxine E Whelan; Peter J Watkinson; Andrew J Farmer
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-08-06       Impact factor: 3.738

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.